Evidence map›Paper›PMID 22588253›Full record

Trial reportPsychopharmacology2012

Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking.

Jane Metrik, Christopher W Kahler, Brady Reynolds, John E McGeary, Peter M Monti, Margaret Haney, Harriet de Wit, Damaris J Rohsenow

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07061886 (Drug Effects on Mood and Behavior - Expectancy), which is not on this map. Cited by 77 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 4 pooled it
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07061886 early_phase1completednot on this mapstarted 2025, after this paper: background citation

Drug Effects on Mood and Behavior - Expectancy

TypeinterventionalSponsorUniversity of ChicagoRan2025 to 2026Enrolled42ConditionsLSDArmsLSD, Placebo
3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 4 syntheses or guidelines pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC).Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. The American journal of drug and alcohol abuse · 2019
    Trial
  9. Marijuana's acute effects on cognitive bias for affective and marijuana cues.Experimental and clinical psychopharmacology · 2015
    Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Use and co-use of alcohol and cannabis following physical pain in the daily life of community adults engaged in regular substance use.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Harnessing placebo: Lessons from psychedelic science.Journal of psychopharmacology (Oxford, England) · 2023
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Jane MetrikCenter for Alcohol and Addiction Studies, Brown University, Box G-S121, Providence, RI 02912, USA. Jane_Metrik@brown.edu
Christopher W Kahler
Brady Reynolds
John E McGeary
Peter M Monti
Margaret Haney
Harriet de Wit
Damaris J Rohsenow
Brown University · USColumbia University · USJohn Brown University · USProvidence College · USThe Ohio State University · USUniversity of Chicago · US

Funding

Marijuana's Acute Effects on Risk Taking, Sexual/HIV risk, and ImpulsivityR01DA021403 · NIDA · BROWN UNIVERSITY · PI METRIK, JANE · 2007 to 2009
$941k
NIDA NIH HHS R01 DA021403
6 · The paper itself

Abstract

rationaleMarijuana is believed to increase impulsivity and risk taking, but the processes whereby it affects such behaviors are not understood. Indeed, either the pharmacologic effect of delta-9-tetrahydrocannabinol (THC) or the expectancy of receiving it may lead to deficits in cognitive processing and increases in risk taking. OBJECTIVES AND

methodsWe examined the relative effects of expecting to receive active marijuana and the pharmacological drug effects using a balanced placebo design. Young adult regular marijuana users (N = 136) were randomly assigned into one of four groups in a two × two instructional set (Told THC vs. Told no THC) by drug administration (smoked marijuana with 2.8 % THC vs. placebo) design. Dependent measures included subjective intoxication, behavioral impulsivity, and decision-making related to risky behaviors.

resultsActive THC, regardless of expectancy, impaired inhibition on the Stop Signal and Stroop Color-Word tasks. Expectancy of having smoked THC, regardless of active drug, decreased impulsive decision-making on a delay discounting task among participants reporting no deception and increased perception of sexual risk among women, consistent with a compensatory effect. Expectancy of smoking THC in combination with active THC increased negative perceptions from risky alcohol use. Active drug and expectancy independently increased subjective intoxication.

conclusionsResults highlight the importance of marijuana expectancy effects as users believing they are smoking marijuana may compensate for expected intoxication effects when engaged in deliberate decision-making by making less impulsive and risky decisions. Effects of marijuana on impulsive disinhibition, by contrast, reflect direct pharmacologic effects for which participants did not compensate.

Indexed as

Risk-TakingAdolescentAdultDecision MakingDronabinolFemaleHumansImpulsive BehaviorMaleMarijuana SmokingPlacebo EffectYoung AdultDronabinol

Identifiers

PMID22588253
PMCPMC3829473
OpenAlexW2039909237

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.